- bDNA Probe Sets
- Characterization Tables
- Custom Products
- P450 Substrates and Metabolites
- RapidStart NADPH Regenerating System
- Recombinant Enzymes
- Subcellular Fractions
- XenoTech Product Promotions
Sign up to receive E-mail notifications when fresh hepatocytes become available.Register now.
Request a Quote
Contact one of our service professionals for a fast and reliable quote. Get started.
Uptake Transporter Characterized Cryopreserved Human Hepatocytes
The uptake and efflux of a drug into and from hepatocytes can determine the rate at which the molecule is metabolized and eliminated from the body. The uptake transporters, including organic anion transporting polypeptides OATP1B1 (OATP2, OATP-C), OATP1B3 (OATP8) OATP2B1 (OATP-B), Na+-taurocholate co-transporting polypeptide (NTCP), organic cation transporter OCT1 and organic anion transporter OAT2, are expressed on the sinusoidal membrane of hepatocytes. These molecules are solute-linked carriers which use an electrochemical gradient of one solute to pump another molecule across the cell membranes and against its concentration gradient. Efflux transporters, multi-drug resistance protein (MDR1, P-gp, ABCB1), MDR3, BSEP (ABCB11, sP-gp), breast cancer resistance protein BCRP (ABCG2), and multi-drug resistance related protein MRP2 (ABCC2), are expressed on the canalicular membrane of hepatocytes and actively transport compounds into the bile. Other “efflux” transporters such as MRP1, 3 and 4 (ABCC1, 3 and 4) are expressed on the sinusoidal membrane of hepatocytes and therefore transport compounds from the cell into the blood.
Human hepatocytes in suspension can be used to evaluate active uptake of compounds into the cells. The uptake of estrone-3-sulfate, taurocholic acid, and 1-methyl-4-phenylpyridinium iodide (MPP+), substrates for OATP1B1, NTCP and OCT1, respectively, into cryopreserved human hepatocytes has been characterized with the method of Hallifax et. al., 2006.
If you are assessing how uptake transporters are affecting the metabolism of your compound, this is the product for you!
View available lots and datasheets here!
- OATP Estrone-3-sulfate
- NTCP Taurocholic Acid
- OCT1 1-Methyl-4-phenylpyridinium lodine
- CYP2D6 Dextromethorphan O-demethylation
- CYP2E1 Chlorzoxazone 6-hydroxylation
- CYP3A4/5 Testosterone 6β-hydroxylation
- UGT Glucronidation of Methylumbelliferone
Donor information (age, ethnicity, gender, cause of death and infectious disease status)
Safety, Handling, and Storage
Cryopreserved hepatocytes should be stored in liquid nitrogen vapor (-160°C or colder). They should be thawed in accordance with our thawing protocol (PDF), which is shipped with your hepatocytes.
Upon thawing, cryopreserved human hepatocytes remain viable and may be used in suspension for short-term drug metabolism experiments (we recommend incubations no longer than 4 hours). When cryopreserved human hepatocytes are thawed, isolated, and suspended under appropriate conditions, they can be used to evaluate the metabolism of drug candidates.
- Cryopreserved Human Hepatocytes
|Product #||Name||Gender||Assured Minimum Yield|
|H1000.H15T||Uptake Transporter Characterized Cryopreserved Human Hepatocytes in Suspension||Male||4 million cells|
|H1500.H15T||Uptake Transporter Characterized Cryopreserved Human Hepatocytes in Suspension||Female||4 million cells|